Cochran EK - Search Results

1

Efficacy of leptin therapy in the different forms of human lipodystrophy.

Chong AY, Lupsa BC, Cochran EK, Gorden P. Chong AY, et al. Among authors: cochran ek. Diabetologia. 2010 Jan;53(1):27-35. doi: 10.1007/s00125-009-1502-9. Epub 2009 Sep 2. Diabetologia. 2010. PMID: 19727665

2

Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.

Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, Premkumar A, Depaoli AM, Skarulis MC, Oral EA, Gorden P. Moran SA, et al. Metabolism. 2004 Apr;53(4):513-9. doi: 10.1016/j.metabol.2003.10.019. Metabolism. 2004. PMID: 15045701 Clinical Trial.

3

Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome.

Cochran E, Young JR, Sebring N, DePaoli A, Oral EA, Gorden P. Cochran E, et al. J Clin Endocrinol Metab. 2004 Apr;89(4):1548-54. doi: 10.1210/jc.2003-031952. J Clin Endocrinol Metab. 2004. PMID: 15070911

4

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.

Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P. Musso C, et al. Medicine (Baltimore). 2004 Jul;83(4):209-222. doi: 10.1097/01.md.0000133625.73570.54. Medicine (Baltimore). 2004. PMID: 15232309 Free article. Review.

5

Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.

Javor ED, Moran SA, Young JR, Cochran EK, DePaoli AM, Oral EA, Turman MA, Blackett PR, Savage DB, O'Rahilly S, Balow JE, Gorden P. Javor ED, et al. Among authors: cochran ek. J Clin Endocrinol Metab. 2004 Jul;89(7):3199-207. doi: 10.1210/jc.2003-032140. J Clin Endocrinol Metab. 2004. PMID: 15240593

6

The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.

Musso C, Cochran E, Javor E, Young J, Depaoli AM, Gorden P. Musso C, et al. Metabolism. 2005 Feb;54(2):255-63. doi: 10.1016/j.metabol.2004.08.021. Metabolism. 2005. PMID: 15690321 Clinical Trial.

7

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.

Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P. Javor ED, et al. Among authors: cochran ek. Hepatology. 2005 Apr;41(4):753-60. doi: 10.1002/hep.20672. Hepatology. 2005. PMID: 15791619 Clinical Trial.

8

The use of U-500 in patients with extreme insulin resistance.

Cochran E, Musso C, Gorden P. Cochran E, et al. Diabetes Care. 2005 May;28(5):1240-4. doi: 10.2337/diacare.28.5.1240. Diabetes Care. 2005. PMID: 15855601 Review. No abstract available.

9

Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth.

Musso C, Shawker T, Cochran E, Javor ED, Young J, Gorden P. Musso C, et al. Clin Endocrinol (Oxf). 2005 Jul;63(1):73-8. doi: 10.1111/j.1365-2265.2005.02302.x. Clin Endocrinol (Oxf). 2005. PMID: 15963065

10

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.

Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Javor ED, et al. Among authors: cochran ek. Diabetes. 2005 Jul;54(7):1994-2002. doi: 10.2337/diabetes.54.7.1994. Diabetes. 2005. PMID: 15983199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters